| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| A Kinase Anchor Proteins | 8 | 2020 | 22 | 4.450 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 9 | 2020 | 234 | 2.230 |
Why?
|
| Myocardium | 17 | 2020 | 1313 | 1.860 |
Why?
|
| Cell Cycle Proteins | 5 | 2020 | 2045 | 1.410 |
Why?
|
| Cyclic AMP | 4 | 2020 | 358 | 0.990 |
Why?
|
| Protein Transport | 2 | 2022 | 734 | 0.810 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2022 | 209 | 0.810 |
Why?
|
| Myocardial Contraction | 9 | 2013 | 291 | 0.810 |
Why?
|
| Cardiomegaly | 4 | 2016 | 195 | 0.790 |
Why?
|
| Diet, High-Fat | 2 | 2019 | 241 | 0.770 |
Why?
|
| Second Messenger Systems | 1 | 2020 | 39 | 0.750 |
Why?
|
| Ventricular Function | 2 | 2020 | 93 | 0.740 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 22 | 0.730 |
Why?
|
| Drug Discovery | 1 | 2022 | 324 | 0.680 |
Why?
|
| Calcium | 12 | 2017 | 1537 | 0.670 |
Why?
|
| Myocytes, Cardiac | 7 | 2016 | 764 | 0.660 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2018 | 18 | 0.630 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 160 | 0.620 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 235 | 0.610 |
Why?
|
| Mechanical Phenomena | 1 | 2017 | 30 | 0.600 |
Why?
|
| Pacemaker, Artificial | 1 | 2020 | 213 | 0.600 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 7222 | 0.600 |
Why?
|
| Troponin I | 3 | 2008 | 127 | 0.600 |
Why?
|
| Pericardium | 1 | 2018 | 157 | 0.590 |
Why?
|
| Intracellular Space | 1 | 2017 | 77 | 0.590 |
Why?
|
| Aortic Diseases | 1 | 2019 | 206 | 0.590 |
Why?
|
| Signal Transduction | 8 | 2019 | 11965 | 0.540 |
Why?
|
| Lipids | 1 | 2019 | 644 | 0.530 |
Why?
|
| Aorta | 1 | 2019 | 692 | 0.520 |
Why?
|
| Calcinosis | 1 | 2018 | 423 | 0.510 |
Why?
|
| Heart Function Tests | 2 | 2016 | 73 | 0.500 |
Why?
|
| Cardiomyopathies | 3 | 2018 | 610 | 0.490 |
Why?
|
| Atherosclerosis | 2 | 2019 | 935 | 0.490 |
Why?
|
| Heart | 5 | 2016 | 1223 | 0.480 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2013 | 97 | 0.460 |
Why?
|
| Membrane Proteins | 1 | 2022 | 2819 | 0.390 |
Why?
|
| HEK293 Cells | 4 | 2022 | 1489 | 0.390 |
Why?
|
| Phosphorylation | 8 | 2019 | 4804 | 0.360 |
Why?
|
| Muscular Atrophy | 2 | 2021 | 105 | 0.350 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2019 | 330 | 0.340 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2008 | 2 | 0.340 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 4549 | 0.320 |
Why?
|
| Heart Failure | 3 | 2020 | 2516 | 0.320 |
Why?
|
| Animals | 29 | 2022 | 59536 | 0.320 |
Why?
|
| Stem Cells | 3 | 2020 | 1213 | 0.310 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 1374 | 0.280 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2195 | 0.250 |
Why?
|
| Isoproterenol | 3 | 2013 | 127 | 0.240 |
Why?
|
| Carrier Proteins | 6 | 2015 | 2022 | 0.230 |
Why?
|
| Peptides | 1 | 2008 | 1479 | 0.220 |
Why?
|
| Mice | 18 | 2022 | 34495 | 0.210 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2001 | 192 | 0.210 |
Why?
|
| Virus Internalization | 1 | 2022 | 88 | 0.200 |
Why?
|
| Binding Sites | 2 | 2018 | 2171 | 0.200 |
Why?
|
| Cell Differentiation | 5 | 2019 | 4078 | 0.200 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 198 | 0.200 |
Why?
|
| Nanotechnology | 1 | 2022 | 137 | 0.200 |
Why?
|
| Sarcomeres | 4 | 2013 | 42 | 0.200 |
Why?
|
| Electrocardiography | 3 | 2018 | 1145 | 0.190 |
Why?
|
| Luciferases | 1 | 2022 | 445 | 0.190 |
Why?
|
| Calcium-Binding Proteins | 4 | 2018 | 545 | 0.180 |
Why?
|
| Adipocytes | 1 | 2022 | 305 | 0.180 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 15 | 0.180 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2020 | 123 | 0.180 |
Why?
|
| Myoblasts | 1 | 2019 | 72 | 0.180 |
Why?
|
| Lysine | 1 | 2022 | 422 | 0.180 |
Why?
|
| Biological Clocks | 1 | 2019 | 45 | 0.180 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 365 | 0.180 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2019 | 44 | 0.180 |
Why?
|
| Sarcoplasmic Reticulum | 4 | 2017 | 191 | 0.170 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2011 | 197 | 0.170 |
Why?
|
| Neointima | 1 | 2019 | 53 | 0.170 |
Why?
|
| Microscopy, Fluorescence | 1 | 2022 | 769 | 0.170 |
Why?
|
| Mutation | 6 | 2017 | 15179 | 0.170 |
Why?
|
| Actin Cytoskeleton | 2 | 2004 | 82 | 0.170 |
Why?
|
| Sequestosome-1 Protein | 1 | 2018 | 39 | 0.170 |
Why?
|
| Protein Binding | 2 | 2018 | 3438 | 0.170 |
Why?
|
| Rats | 7 | 2011 | 6086 | 0.170 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2018 | 49 | 0.170 |
Why?
|
| Cardiotonic Agents | 2 | 2011 | 151 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 488 | 0.160 |
Why?
|
| Mice, Knockout | 5 | 2022 | 5710 | 0.160 |
Why?
|
| Gene Expression Regulation | 6 | 2022 | 4053 | 0.160 |
Why?
|
| Echocardiography | 4 | 2018 | 1182 | 0.160 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 521 | 0.150 |
Why?
|
| Heart Ventricles | 8 | 2015 | 846 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2019 | 396 | 0.150 |
Why?
|
| Excitation Contraction Coupling | 1 | 2017 | 12 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2019 | 246 | 0.150 |
Why?
|
| Cytosol | 2 | 2017 | 238 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 460 | 0.150 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1997 | 137 | 0.150 |
Why?
|
| Mice, SCID | 2 | 2018 | 1869 | 0.150 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 630 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 323 | 0.140 |
Why?
|
| Sarcolemma | 1 | 2016 | 32 | 0.140 |
Why?
|
| Histone Chaperones | 1 | 2016 | 32 | 0.140 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 338 | 0.140 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 1270 | 0.140 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1070 | 0.130 |
Why?
|
| Mice, Mutant Strains | 3 | 2013 | 634 | 0.130 |
Why?
|
| Cytokinesis | 1 | 2015 | 57 | 0.130 |
Why?
|
| Myosin Heavy Chains | 3 | 2000 | 128 | 0.130 |
Why?
|
| Acetylcysteine | 1 | 2016 | 143 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 6942 | 0.130 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2013 | 103 | 0.120 |
Why?
|
| Cricetulus | 1 | 2013 | 205 | 0.110 |
Why?
|
| CHO Cells | 1 | 2013 | 311 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 622 | 0.110 |
Why?
|
| Substrate Specificity | 1 | 2013 | 549 | 0.110 |
Why?
|
| Autophagy | 1 | 2018 | 927 | 0.110 |
Why?
|
| Cricetinae | 1 | 2013 | 706 | 0.110 |
Why?
|
| Male | 15 | 2022 | 123000 | 0.110 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 1 | 2011 | 16 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 280 | 0.100 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2011 | 17 | 0.100 |
Why?
|
| Propanolamines | 1 | 2011 | 44 | 0.100 |
Why?
|
| Humans | 15 | 2022 | 261506 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 644 | 0.100 |
Why?
|
| Milrinone | 1 | 2011 | 33 | 0.100 |
Why?
|
| Phenotype | 3 | 2018 | 6295 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2011 | 2063 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2021 | 116 | 0.090 |
Why?
|
| Liver | 1 | 2019 | 2961 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 1360 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2013 | 1442 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 739 | 0.080 |
Why?
|
| Electric Stimulation | 3 | 1998 | 426 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2021 | 2947 | 0.080 |
Why?
|
| Hypertension | 1 | 1997 | 1503 | 0.080 |
Why?
|
| Rats, Inbred WKY | 2 | 1998 | 110 | 0.080 |
Why?
|
| Rats, Inbred SHR | 2 | 1998 | 113 | 0.080 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 475 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2019 | 5637 | 0.080 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2008 | 244 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1237 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2008 | 577 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2019 | 5270 | 0.070 |
Why?
|
| Acute Disease | 1 | 2011 | 2422 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2019 | 7226 | 0.060 |
Why?
|
| Transcriptome | 3 | 2019 | 1859 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 2001 | 682 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2008 | 1459 | 0.060 |
Why?
|
| Acylation | 1 | 2022 | 25 | 0.050 |
Why?
|
| 3T3-L1 Cells | 1 | 2022 | 77 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2021 | 45 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 1371 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2019 | 6150 | 0.050 |
Why?
|
| Anesthetics, Intravenous | 1 | 2001 | 73 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2001 | 68 | 0.050 |
Why?
|
| Propofol | 1 | 2001 | 80 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2016 | 5542 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2001 | 333 | 0.050 |
Why?
|
| Gene Expression | 1 | 2008 | 3570 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2019 | 71 | 0.050 |
Why?
|
| Family Health | 1 | 2001 | 325 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 75 | 0.040 |
Why?
|
| Connexins | 1 | 2019 | 78 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2001 | 370 | 0.040 |
Why?
|
| Transgenes | 1 | 2001 | 557 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2018 | 80 | 0.040 |
Why?
|
| Actomyosin | 1 | 1998 | 11 | 0.040 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1997 | 8 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1997 | 13 | 0.040 |
Why?
|
| Marine Toxins | 1 | 1997 | 12 | 0.040 |
Why?
|
| Prazosin | 1 | 1997 | 22 | 0.040 |
Why?
|
| Actins | 1 | 2001 | 608 | 0.040 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1997 | 28 | 0.040 |
Why?
|
| Colforsin | 1 | 1997 | 59 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2001 | 473 | 0.040 |
Why?
|
| Myosin Light Chains | 1 | 1997 | 23 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2018 | 133 | 0.040 |
Why?
|
| Oxazoles | 1 | 1997 | 60 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 842 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2001 | 435 | 0.040 |
Why?
|
| Phosphates | 1 | 1998 | 187 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 1062 | 0.040 |
Why?
|
| Receptors, Purinergic | 1 | 1996 | 15 | 0.040 |
Why?
|
| Wnt3A Protein | 1 | 2016 | 29 | 0.040 |
Why?
|
| Norepinephrine | 1 | 1997 | 272 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2016 | 47 | 0.040 |
Why?
|
| Renal Agents | 1 | 2016 | 6 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 101 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 461 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 142 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 80 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 214 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 1217 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2001 | 1152 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1998 | 435 | 0.030 |
Why?
|
| Aurora Kinases | 1 | 2015 | 189 | 0.030 |
Why?
|
| Alleles | 1 | 2001 | 2437 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2019 | 1450 | 0.030 |
Why?
|
| Dependovirus | 1 | 2015 | 135 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 699 | 0.030 |
Why?
|
| Mesoderm | 1 | 2016 | 404 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 508 | 0.030 |
Why?
|
| Heart Rate | 2 | 2011 | 737 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1994 | 52 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2018 | 665 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 1879 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 668 | 0.030 |
Why?
|
| Myofibrils | 2 | 2004 | 31 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 4917 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2018 | 1152 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 1391 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 492 | 0.030 |
Why?
|
| Fetus | 1 | 2016 | 601 | 0.030 |
Why?
|
| Receptors, Opioid, delta | 1 | 2011 | 26 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 2466 | 0.030 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2011 | 8 | 0.030 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2011 | 17 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2004 | 600 | 0.020 |
Why?
|
| Propranolol | 1 | 2011 | 156 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 1338 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2011 | 163 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 448 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 2004 | 1618 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2016 | 1274 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 2508 | 0.020 |
Why?
|
| Indoles | 1 | 2015 | 1009 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 1129 | 0.020 |
Why?
|
| Apoptosis | 2 | 2016 | 7591 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 323 | 0.020 |
Why?
|
| Neutrophils | 1 | 1994 | 835 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 2216 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2015 | 1048 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 1382 | 0.020 |
Why?
|
| Homozygote | 2 | 2001 | 717 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 2 | 1999 | 60 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 3260 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 1872 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 1466 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 1954 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 2594 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 12926 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 2083 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 3254 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2011 | 1271 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 6009 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 1467 | 0.020 |
Why?
|
| Papillary Muscles | 1 | 2004 | 27 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2004 | 168 | 0.010 |
Why?
|
| Biomarkers | 1 | 2015 | 5047 | 0.010 |
Why?
|
| Connexin 43 | 1 | 2003 | 46 | 0.010 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 40 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2003 | 52 | 0.010 |
Why?
|
| Adenosine Triphosphate | 2 | 1996 | 571 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12221 | 0.010 |
Why?
|
| Calcineurin | 1 | 2003 | 128 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 2001 | 18 | 0.010 |
Why?
|
| Myosins | 1 | 2001 | 96 | 0.010 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2001 | 69 | 0.010 |
Why?
|
| Minoxidil | 1 | 2000 | 8 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 1999 | 4143 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2001 | 165 | 0.010 |
Why?
|
| Calcineurin Inhibitors | 1 | 2000 | 68 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2000 | 278 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2000 | 335 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 17523 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 185 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 1020 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2001 | 875 | 0.010 |
Why?
|
| Oscillometry | 1 | 1996 | 26 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 1399 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1996 | 38 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1996 | 65 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1996 | 108 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 204 | 0.010 |
Why?
|
| Heart Atria | 1 | 1999 | 352 | 0.010 |
Why?
|
| Action Potentials | 1 | 1999 | 560 | 0.010 |
Why?
|
| Caffeine | 1 | 1996 | 87 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 70117 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 32848 | 0.010 |
Why?
|
| Bucladesine | 1 | 1994 | 31 | 0.010 |
Why?
|
| Aluminum Compounds | 1 | 1994 | 17 | 0.010 |
Why?
|
| Calcimycin | 1 | 1994 | 48 | 0.010 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1994 | 38 | 0.010 |
Why?
|
| Fluorides | 1 | 1994 | 25 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1994 | 43 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 226 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1994 | 118 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 86204 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 568 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 3045 | 0.010 |
Why?
|
| Kinetics | 1 | 1994 | 2049 | 0.010 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1994 | 430 | 0.010 |
Why?
|
| Female | 2 | 2016 | 141928 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 9180 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 5539 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 4938 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1994 | 3536 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 5395 | 0.000 |
Why?
|
| Cell Line | 1 | 1994 | 5114 | 0.000 |
Why?
|